Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Applications of gold nanoparticles in cancer nanotechnology.

Cai W, Gao T, Hong H, Sun J.

Nanotechnol Sci Appl. 2008 Sep 19;1:17-32. Review.

2.

Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.

Nam T, Park S, Lee SY, Park K, Choi K, Song IC, Han MH, Leary JJ, Yuk SA, Kwon IC, Kim K, Jeong SY.

Bioconjug Chem. 2010 Apr 21;21(4):578-82. doi: 10.1021/bc900408z.

PMID:
20201550
3.

Molecular imaging and therapy of cancer with radiolabeled nanoparticles.

Hong H, Zhang Y, Sun J, Cai W.

Nano Today. 2009 Oct 1;4(5):399-413.

4.

Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.

Willmann JK, Kimura RH, Deshpande N, Lutz AM, Cochran JR, Gambhir SS.

J Nucl Med. 2010 Mar;51(3):433-40. doi: 10.2967/jnumed.109.068007. Epub 2010 Feb 11.

5.

A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.

Kimura RH, Miao Z, Cheng Z, Gambhir SS, Cochran JR.

Bioconjug Chem. 2010 Mar 17;21(3):436-44. doi: 10.1021/bc9003102. Epub 2010 Feb 4.

6.

Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imaging.

Li F, Liu J, Jas GS, Zhang J, Qin G, Xing J, Cotes C, Zhao H, Wang X, Diaz LA, Shi ZZ, Lee DY, Li KC, Li Z.

Bioconjug Chem. 2010 Feb 17;21(2):270-8. doi: 10.1021/bc900313d.

PMID:
20102181
7.

Molecular imaging in gastrointestinal endoscopy.

Goetz M, Wang TD.

Gastroenterology. 2010 Mar;138(3):828-33.e1. doi: 10.1053/j.gastro.2010.01.009. Epub 2010 Jan 21. Review.

8.

PET/NIRF/MRI triple functional iron oxide nanoparticles.

Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X, Chen X.

Biomaterials. 2010 Apr;31(11):3016-22. doi: 10.1016/j.biomaterials.2010.01.010. Epub 2010 Jan 21.

9.

New strategies for fluorescent probe design in medical diagnostic imaging.

Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y.

Chem Rev. 2010 May 12;110(5):2620-40. doi: 10.1021/cr900263j. Review. No abstract available.

10.

The use of fluorescent dyes and probes in surgical oncology.

Te Velde EA, Veerman T, Subramaniam V, Ruers T.

Eur J Surg Oncol. 2010 Jan;36(1):6-15. doi: 10.1016/j.ejso.2009.10.014. Epub 2009 Nov 18. Review.

PMID:
19926438
11.

Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection.

Ogawa M, Regino CA, Seidel J, Green MV, Xi W, Williams M, Kosaka N, Choyke PL, Kobayashi H.

Bioconjug Chem. 2009 Nov;20(11):2177-84. doi: 10.1021/bc900362k.

12.

In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.

Goetz M, Ziebart A, Foersch S, Vieth M, Waldner MJ, Delaney P, Galle PR, Neurath MF, Kiesslich R.

Gastroenterology. 2010 Feb;138(2):435-46. doi: 10.1053/j.gastro.2009.10.032. Epub 2009 Oct 21.

PMID:
19852961
13.

Nuclear imaging of molecular processes in cancer.

Torres Martin de Rosales R, Arstad E, Blower PJ.

Target Oncol. 2009 Sep;4(3):183-97. doi: 10.1007/s11523-009-0120-2. Epub 2009 Sep 25. Review. Erratum in: Target Oncol. 2009 Sep;4(3):199.

PMID:
19779864
14.

Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.

Ogawa M, Kosaka N, Longmire MR, Urano Y, Choyke PL, Kobayashi H.

Mol Pharm. 2009 Mar-Apr;6(2):386-95. doi: 10.1021/mp800115t.

15.

A novel type of dual-modality molecular probe for MR and nuclear imaging of tumor: preparation, characterization and in vivo application.

Liu S, Jia B, Qiao R, Yang Z, Yu Z, Liu Z, Liu K, Shi J, Ouyang H, Wang F, Gao M.

Mol Pharm. 2009 Jul-Aug;6(4):1074-82. doi: 10.1021/mp900143a.

PMID:
19527074
16.

Hybrid imaging technology: from dreams and vision to clinical devices.

Patton JA, Townsend DW, Hutton BF.

Semin Nucl Med. 2009 Jul;39(4):247-63. doi: 10.1053/j.semnuclmed.2009.03.005. Review.

PMID:
19497402
17.

Synthesis and evaluation of a novel hydroxamate based fluorescent photoprobe for imaging of matrix metalloproteinases.

Faust A, Waschkau B, Waldeck J, Höltke C, Breyholz HJ, Wagner S, Kopka K, Schober O, Heindel W, Schäfers M, Bremer C.

Bioconjug Chem. 2009 May 20;20(5):904-12. doi: 10.1021/bc8004478.

PMID:
19374404
18.

Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes.

Villa CH, McDevitt MR, Escorcia FE, Rey DA, Bergkvist M, Batt CA, Scheinberg DA.

Nano Lett. 2008 Dec;8(12):4221-8. doi: 10.1021/nl801878d.

19.

Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.

Chang CH, Stabin MG, Chang YJ, Chen LC, Chen MH, Chang TJ, Lee TW, Ting G.

Cancer Biother Radiopharm. 2008 Dec;23(6):749-58. doi: 10.1089/cbr.2008.0489.

PMID:
19111045
20.

Antibodies and antimatter: the resurgence of immuno-PET.

Wu AM.

J Nucl Med. 2009 Jan;50(1):2-5. doi: 10.2967/jnumed.108.056887. Epub 2008 Dec 17. Review.

Supplemental Content

Support Center